Loading
Latest filing published 07 Oct 2026 for Arbutus Biopharma Corporation, €53k. Read the official filing
Roger Sawhney is a declared insider of Arbutus Biopharma Corporation, with filings sourced from SEDI. In total, 8 filings cover trades dated from 4 August 2025 to 1 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 7 October 2026 came the latest disclosure, a transaction for €53k in Arbutus Biopharma Corporation. The median gap between a trade and its publication by SEDI is 5 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations